Efficiency of Immunotoxin Cytotoxicity Is Modulated by the Intracellular Itinerary

Pseudomonas exotoxin-based immunotoxins, including LMB-2 (antiTac(Fv)-PE38), are proposed to traffic to the trans-Golgi network (TGN) and move by a retrograde pathway to the endoplasmic reticulum, where they undergo translocation to the cytoplasm, a step that is essential for cytotoxicity. The retrograde transport pathways used by LMB-2 are not completely understood, so it is unclear if transit through specific organelles is critical for maximal cytotoxic activity. In this study, we used Chinese hamster ovary (CHO) cell lines that express chimeric constructs of CD25, the Tac antigen, attached to the cytoplasmic domain of the TGN-targeted transmembrane proteins, TGN38 and furin. These chimeras are both targeted to the TGN, but the itineraries they follow are quite different. LMB-2 was incubated with the two cell lines, and the efficiency of cell killing was determined using cell viability and cytotoxicity assays. LMB-2 that is targeted through the endocytic recycling compartment to the TGN via Tac-TGN38 kills the cells more efficiently than immunotoxins delivered through the late endosomes by Tac-furin. Although the processing to the 37 kDa active fragment was more efficient in Tac-furin cells than in Tac-TGN38 cells, this was not associated with enhanced cytotoxicity – presumably because the toxin was also degraded more rapidly in these cells. These data indicate that trafficking through specific organelles is an important factor modulating toxicity by LMB-2.

[1]  R. Kreitman Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies , 2012, BioDrugs.

[2]  I. Pastan,et al.  A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. , 2009, Blood.

[3]  P. Wolf,et al.  Pseudomonas exotoxin A: from virulence factor to anti-cancer agent. , 2009, International journal of medical microbiology : IJMM.

[4]  J. Murray,et al.  Internalized Pseudomonas Exotoxin A can Exploit Multiple Pathways to Reach the Endoplasmic Reticulum , 2006, Traffic.

[5]  F. Maxfield,et al.  Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells Published, JLR Papers in Press, November 15, 2005. , 2006, Journal of Lipid Research.

[6]  D. Kuhn,et al.  The role of interleukin-2 receptor alpha in cancer. , 2005, Frontiers in bioscience : a journal and virtual library.

[7]  F. Maxfield,et al.  Role of cytoplasmic domain serines in intracellular trafficking of furin. , 2004, Molecular biology of the cell.

[8]  F. Maxfield,et al.  Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes. , 2003, Molecular biology of the cell.

[9]  Leonid A. Khinkis,et al.  Optimal Design for Estimating Parameters of the 4-Parameter Hill Model , 2003, Nonlinearity in biology, toxicology, medicine.

[10]  I. Pastan Immunotoxins containing Pseudomonas exotoxin A: a short history , 2003, Cancer Immunology, Immunotherapy.

[11]  A. Dautry‐Varsat,et al.  Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. , 2001, Molecular cell.

[12]  I. Pastan,et al.  Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies , 2000, International journal of cancer.

[13]  M. McKee,et al.  Reduction of furin-nicked Pseudomonas exotoxin A: an unfolding story. , 1999, Biochemistry.

[14]  I. Pastan,et al.  Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  F. Maxfield,et al.  Chimeric Forms of Furin and Tgn38 Are Transported from the Plasma Membrane to the Trans-Golgi Network via Distinct Endosomal Pathways , 1999, The Journal of cell biology.

[16]  W R Greco,et al.  Modeling of the time-dependency of in vitro drug cytotoxicity and resistance. , 1998, Cancer research.

[17]  I. Pastan,et al.  Role of caspases in immunotoxin-induced apoptosis of cancer cells. , 1998, Biochemistry.

[18]  F. Maxfield,et al.  An Endocytosed TGN38 Chimeric Protein Is Delivered to the TGN after Trafficking through the Endocytic Recycling Compartment in CHO Cells , 1998, The Journal of cell biology.

[19]  M. Chiron,et al.  Furin-mediated Cleavage of Pseudomonas Exotoxin-derived Chimeric Toxins* , 1997, The Journal of Biological Chemistry.

[20]  K. Nakayama,et al.  Localization of Furin to the trans-Golgi Network and Recycling from the Cell Surface Involves Ser and Tyr Residues within the Cytoplasmic Domain (*) , 1995, The Journal of Biological Chemistry.

[21]  M. Vey,et al.  Two independent targeting signals in the cytoplasmic domain determine trans‐Golgi network localization and endosomal trafficking of the proprotein convertase furin. , 1995, The EMBO journal.

[22]  E Morelon,et al.  Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains , 1995, The Journal of cell biology.

[23]  T. Moehring,et al.  Furin activates Pseudomonas exotoxin A by specific cleavage in vivo and in vitro. , 1994, The Journal of biological chemistry.

[24]  J. Bonifacino,et al.  The cytoplasmic domain mediates localization of furin to the trans- Golgi network en route to the endosomal/lysosomal system , 1994, The Journal of cell biology.

[25]  M. Chiron,et al.  Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. , 1994, The Journal of biological chemistry.

[26]  G. Thomas,et al.  Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. , 1994, The EMBO journal.

[27]  I. Pastan,et al.  Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. , 1994, Blood.

[28]  K. Howell,et al.  A cytosolic complex of p62 and rab6 associates with TGN38/41 and is involved in budding of exocytic vesicles from the trans-Golgi network , 1993, The Journal of cell biology.

[29]  C. Wraight,et al.  TGN38 is maintained in the trans‐Golgi network by a tyrosine‐containing motif in the cytoplasmic domain. , 1993, The EMBO journal.

[30]  I. Pastan,et al.  Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds. , 1993, Bioconjugate chemistry.

[31]  Barbara J. Reaves,et al.  TGN38/41 recycles between the cell surface and the TGN: brefeldin A affects its rate of return to the TGN. , 1993, Molecular biology of the cell.

[32]  W. P. Schneider,et al.  Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor. , 1992, Journal of immunology.

[33]  I. Pastan,et al.  A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing. , 1992, The Journal of biological chemistry.

[34]  D. Strickland,et al.  The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. , 1992, The Journal of biological chemistry.

[35]  D. Hoessli,et al.  Isolation of high‐affinity murine interleukin 2 receptors as detergent‐resistant membrane complexes , 1990, European journal of immunology.

[36]  S. Kornfeld,et al.  Intracellular movement of two mannose 6-phosphate receptors: return to the Golgi apparatus , 1988, The Journal of cell biology.

[37]  D. J. Finney,et al.  Guidelines for immunoassay data processing. , 1985, Clinical chemistry.